title: Olanzapine-induced leucopenia and neutropenia.
abstract: Atypical antipsychotics, including olanzapine, were originally expected to reduce the risk of haematological toxicity and to be safe alternatives to clozapine. We report a case of patient who developed leucopenia and neutropenia during treatment with olanzapine.
authors.affiliation: 2nd Department of Psychiatry, Aristotle University of Thessaloniki, Greece.
authors.forename: Vasilis
authors.initials: V
authors.lastname: Stergiou
authors.forename: Vasilis P
authors.initials: VP
authors.lastname: Bozikas
authors.forename: George
authors.initials: G
authors.lastname: Garyfallos
authors.forename: Nikolas
authors.initials: N
authors.lastname: Nikolaidis
authors.forename: Grigoris
authors.initials: G
authors.lastname: Lavrentiadis
authors.forename: Kostas
authors.initials: K
authors.lastname: Fokas
mesh_terms: D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000188:drug therapy; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced*; D008297:Male; D009503:Neutropenia / Q000139:chemically induced*; D000077152:Olanzapine
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine